期刊文献+

心力衰竭恶病质大鼠PI3K/Akt信号转导通路的变化 被引量:1

Phosphoinositide 3-kinase/protein kinase B(PI3K/AKT) signaling pathway in rat with cardiac cachexia
原文传递
导出
摘要 目的:探讨磷脂酰肌醇3激酶/蛋白激酶B(PI3K/Akt)信号转导通路是否参与心力衰竭(心衰)恶病质的发生。方法:通过使用异丙肾上腺素制备大鼠心衰恶病质模型,根据体重和心脏彩超结果将大鼠分为心衰恶病质组、心衰非恶病质组及对照组。采用ELISA法检测3组大鼠血清胰岛素、胰岛素样生长因子-1(IGF-1)浓度;采用免疫组织化学法检测3组大鼠心肌组织中p85、p-Akt的表达情况;采用RT-PCR法检测3组大鼠心肌组织中caspase9mRNA、Bcl-xl mRNA的表达情况。结果:1胰岛素水平:心衰恶病质组显著高于非恶病质组(P<0.05)和对照组(P<0.05),但心衰非恶病质组低于对照组(P<0.05);2IGF-1水平:心衰恶病质组低于非恶病质组(P<0.05),与对照组之间无显著差异(P>0.05),但心衰非恶病质组高于对照组(P<0.05);3心肌组织p85、p-Akt的表达情况:心衰恶病质组低于非恶病质组(P<0.05)和对照组(P<0.05),但心衰非恶病质组高于对照组(P<0.05);4心肌组织caspase9mRNA的表达情况:心衰恶病质组高于非恶病质组(P<0.05)和对照组(P<0.05),但心衰非恶病质组低于对照组(P<0.05);5心肌组织Bcl-xl mRNA的表达情况:心衰恶病质组低于非恶病质组(P<0.05)和对照组(P<0.05),但心衰非恶病质组高于对照组(P<0.05)。结论:在ISO所致的大鼠心衰恶病质体内存在胰岛素及生长激素抵抗,PI3K/Akt信号转导通路受到抑制,PI3K/Akt信号转导通路参与心衰恶病质的发生。 Objective:To explore whether the phosphoinositide 3-kinase/protein kinase B(PI3K/AKT)signaling pathway was related to the occurrence of isoproterenol(ISO)-induced cardiac cachexia.Method:The rat model with cardiac cachexia was administered with ISO of 180mg/kg·d via inguinal subcutaneous injection.The rats were divided into cardiac cachexia group,no cachexia group and control group,according to the changes of body weight and the echocardiography results.The levels of insulin and Insulin-like growth factor-1(IGF-1)in the serum of all rats were detected by enzyme-linked immunosorbent assay(ELISA);the expression of p85 and p-Akt in the myocardial tissue of all rats were detected by immunohistochemical;the expression of caspase9 mRNA and Bcl-xl mRNA in the myocardial tissue of all rats were detected by reverse transcription polymerase chain reaction(RT-PCR).Result:The levels of insulin in cardiac cachexia group was significantly higher than that in both no cachexia group and control group(P0.05),but was lower in no cachexia group than the control group(P0.05);the levels of IGF-1in cardiac cachexia group was lower than in the no cachexia group(P0.05),the heart failure non cachexia group was higher than the control group(P0.05),while there were no satistically significantly differernces between cardiac cachexia group and control group(P0.05);the expression of p85 and p-Akt in the cardiac cachexia group was lower than those in both no cachexia group(P0.05)and control group(P0.05),but was higher in the no cachexia group than the control group(P0.05);the expression of caspase9 mRNA in the myocardial tissue of rats:in cardiac cachexia group was higher than in the heart failure non cachexia group(P0.05)and control group(P0.05),but the heart failure non cachexia group was lower than the control group(P0.05);he expression of Bcl-xl mRNA in the myocardial tissue of rats:in cardiac cachexia group was lower than in the heart failure non cachexia group(P
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2016年第6期585-590,共6页 Journal of Clinical Cardiology
基金 内蒙古自治区高等学校"青年科技英才支持计划"(No:NJYT-14-B21)
关键词 心力衰竭 恶病质 磷脂酰肌醇3激酶/蛋白激酶B 信号转导通路 heart failure cachexia phosphoinositide 3-kinase/protein kinase B signaling pathway
  • 相关文献

参考文献13

  • 1PALUS S, SCHUR R, AKASHI Y J, et al. Ghrelin and its analogues, BIM 28131 and BIM-28125, improve body weight and regulate the expression of MuRF-1 and mafbx in a ratheart failure mode[J]. PLoS One, 2011, 6: 1--2. 被引量:1
  • 2GENG T, LI P, YIN X ,et al. PGC-la promotes ni- tric oxide antioxidant defenses and inhibits FOXO sig- naling against cardiac cachexia in mice [J]. Am J Pathol, 2011, 178: 1738--1748. 被引量:1
  • 3OP DEN KAMP C M, LANGEN R C, SNEPVANGERS F J, et al. Nuclear transcription factor B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia[J]. Am J Clin Nutr, 2013, 98:738--748. 被引量:1
  • 4TANADA Y, SHIOI T, KATO T, et al. Branched- chain amino acids ameliorate heart failure with cardiac cachexia in rats[J]. Life Sci, 2015,137:20--27. 被引量:1
  • 5王玉强,盛净.磷脂酰肌醇3-激酶对心脏的调节[J].现代生物医学进展,2011,11(13):2578-2580. 被引量:2
  • 6SIEDNIENKO J, JANKOWSKA E A, BANASIAK W, et al. Nuclear factor-kappaB activity in peripheral blood mononuclear cells in cachectic and non-cachectic patients with chronic heart failure [J]. Int J Cardio[, 2007, 122:111--116. 被引量:1
  • 7XIN M, DENG X. Nicotine inactivation of the pro- apoptotic function of Bax through phosphorylation [J]. BiolChem, 2005, 280:107--112. 被引量:1
  • 8WALTHER S, AWAD S, LONCHYNA V A, et al. NFAT transcription factor regulation by urocortin I1 in cardiac myocytes and heart failure [J]. Am J Physi ol Heart Circ Physiol, 2014, 17:9 13. 被引量:1
  • 9付锋..胰岛素对大鼠心肌梗死后心室重塑和功能的影响及机制[D].第四军医大学,2011:
  • 10周南南,卓晶明,东燕,李春梅.心力衰竭并恶液质患者血清脂联素水平与BMI、脑钠肽的关系[J].山东医药,2011,51(45):21-22. 被引量:2

二级参考文献42

  • 1Tao w. The mitotic checkpoint in cancer therapy [J]. Cell Cycle, 2005,4(11): 1495-1499. 被引量:1
  • 2Philipp V,carsten,Bemd N,et al. Assigning functional domains within tile p101 regulatory subunit ofphos-phoinositide 3.kinase[J]. J Biol Chem,2005,280(6):5121-5127. 被引量:1
  • 3Luo J, McMullen JR, Sobkiw CL, et al.Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy[J]. Molecular Cell Biology, 2005,25(21):9491-9502. 被引量:1
  • 4Kim KH, Oudit GY, Backx PH. Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway[J]. J Pharmacol Exp Ther,2008,324(1): 160-169. 被引量:1
  • 5DeBosch B, Sambandam N, Weinheimer Cct al. Akt2 regulates cardiac metabolism and cardiomyocyte survival [J]. J Biol Chem,2006,281 (43):32841-32851. 被引量:1
  • 6McMullen, J. R. Jermings, G. L. Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure[J]. Clin. Exp. Pharmacol. Physiol, 2007,34(4): 255-262. 被引量:1
  • 7McMullen, J. R., Shioi, T., Huang, W. Y. et al. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase (p110a ) pathway [J]. J. Biol. Chem, 2004,279(6): 4782-4793. 被引量:1
  • 8Muslin AJ, DeBosch B. Role of Akt in cardiac growth and metabolism[J].Novartis Found Syrup,2006,274:118-126. 被引量:1
  • 9McMullen JR,Izumo S. Role of the insulin-like growth factor 1 (IGF1) / phosphoinositide3-kinase (PI3K) pathway mediating physiological cardiac hypertrophy [J]. Novartis Found Syrup, 2006,274: 90-111. 被引量:1
  • 10Patrucco E, Notte A, Barberis L, et al. PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects[J]. Cell ,2004,118(3): 375-387. 被引量:1

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部